SINERGIAS ENTRE EL SECTOR SANITARIO
(HOSPITALARIO)Y EL EMPRESARIAL
JOSEV. CASTELL PHD, MD
DIRECTOR
UNIVERSITY HOSPITALS :
BIOMEDICAL
RESEARCH
MEDICALTRAINING
HEALTHCARE
HIGHLY QUALIFIED PERSONNEL +
ADVANCED TECHNOLOGIES
GREAT INNOVATIVE POTENTIAL …
4
Potential ideas / value run out…
Clinical care
Recovering “energy” : a co-generation model?
INNOVATION IN UNIVERSITY HOSPITALS
BIOMEDICAL
RESEARCH
INNOVATION
MEDICAL
TRAINING
HEALTHCARE
INTEGRATING INNOVATION IN HOSPITAL ACTIVITY
 Innovation is NOT a first priority in hospitals
 Innovation should be integ...
Ideas / biomedical research
Strategic Validation Process
Prototypes – Proof of concept
Integration in healthcare practice
...
Idea / biomedical research
Strategic Validation Process
Prototype – Proof of concept
Diffusion and adoption in Healthcare
...
The clinical proof of
concept/validation
Other partners needed??
working with strategic partners
Idea Licencing-SME Valorization Commercialization
Large investments
not always affordable
Ideas Licencing-SME Valorization Commercialization
“ ”
 Linking agents of the Science-
technology-Enterprise System, to
accelerate the process of
valorization, transferability ...
Biopole: 15.400 m2
Medical Faculty &
Management area:
13.500m2
Medical Care area: 166.400 m2
22
SME/ IIS La Fe Partnership
IDEA /
PRODUCT
CRUnit
(biomedicalcontract
researchUnit)
PLATFORMS
The IIS La Fe offers scientific and technological services with more than 10,000 m2 of
clinical and research lab...
PRE-CLINICAL
TOXICITY
PLATFORM
Cell Culture Models
cellculture_toxicity@iislafe.es
Genotoxicity Hepatotoxicity Phototoxici...
RESEARCH OMIC
PLATFORM
Genomics
genomics@iislafe.es
Arrays
arrays_service@iislafe.es
Genotiping and
Sequencing Cytogenetic...
Offers a customised global GLP
service:
- including analytical services,
- consultancy, as well as
- the development of an...
Enzymatic
activities
Biomarkers
Metabolomic
profile
Secondary
metabolism
compounds
Signal
transduction
molecules
Target mo...
IDEA /
PRODUCT
Stock Options or Shares,
Capital return
Costs paid in
valorization Procces
SHARING FUTURE VALUE
www.iislafe.es
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
01_Taller SALUD: José Vicente Castell_ISS La Fe
Upcoming SlideShare
Loading in …5
×

01_Taller SALUD: José Vicente Castell_ISS La Fe

173
-1

Published on

Published in: Business, Technology
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
173
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
16
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

01_Taller SALUD: José Vicente Castell_ISS La Fe

  1. 1. SINERGIAS ENTRE EL SECTOR SANITARIO (HOSPITALARIO)Y EL EMPRESARIAL JOSEV. CASTELL PHD, MD DIRECTOR
  2. 2. UNIVERSITY HOSPITALS : BIOMEDICAL RESEARCH MEDICALTRAINING HEALTHCARE
  3. 3. HIGHLY QUALIFIED PERSONNEL + ADVANCED TECHNOLOGIES
  4. 4. GREAT INNOVATIVE POTENTIAL … 4
  5. 5. Potential ideas / value run out… Clinical care
  6. 6. Recovering “energy” : a co-generation model?
  7. 7. INNOVATION IN UNIVERSITY HOSPITALS BIOMEDICAL RESEARCH INNOVATION MEDICAL TRAINING HEALTHCARE
  8. 8. INTEGRATING INNOVATION IN HOSPITAL ACTIVITY  Innovation is NOT a first priority in hospitals  Innovation should be integrated and be part of the current activity of health professionals  Support structures should be implemented in order to “extract” potential innovations out of clinical knowledge
  9. 9. Ideas / biomedical research Strategic Validation Process Prototypes – Proof of concept Integration in healthcare practice Successful INNOVATION is complex Intellectual Property Rights IPRs ClinicalValidation Commercialization Feedback and improvement
  10. 10. Idea / biomedical research Strategic Validation Process Prototype – Proof of concept Diffusion and adoption in Healthcare Intellectual Property Rights IPRs ClinicalValidation Commercialization Feedback and improvement Successful INNOVATION is complex
  11. 11. The clinical proof of concept/validation Other partners needed?? working with strategic partners
  12. 12. Idea Licencing-SME Valorization Commercialization Large investments not always affordable
  13. 13. Ideas Licencing-SME Valorization Commercialization “ ”
  14. 14.  Linking agents of the Science- technology-Enterprise System, to accelerate the process of valorization, transferability and the way to market in the field of biomedical research  Hosting biomedical enterprises Basic Research Clinical Reseach Valorization and Innovation Transfer to product developers
  15. 15. Biopole: 15.400 m2 Medical Faculty & Management area: 13.500m2 Medical Care area: 166.400 m2 22
  16. 16. SME/ IIS La Fe Partnership
  17. 17. IDEA / PRODUCT
  18. 18. CRUnit (biomedicalcontract researchUnit)
  19. 19. PLATFORMS The IIS La Fe offers scientific and technological services with more than 10,000 m2 of clinical and research laboratories CRUnit Omic Platform Genomics Cytomics Analitycal Unit Biomedical Research Support Pre-Clinical Toxicity Platform Cell Culture Models Animal Models Clinical Genetic Platform Pharmacogenetics Cytogenetic Analysis Genetic Anlysis
  20. 20. PRE-CLINICAL TOXICITY PLATFORM Cell Culture Models cellculture_toxicity@iislafe.es Genotoxicity Hepatotoxicity Phototoxicity Animal Models animalmodel_toxicity@iislafe.es Drug and Food Toxicity Ecotoxicity Coordinates preclinical or environmental studies in different levels of complexity from in vitro cellular models to animal models for a wide variety of toxicological studies. The know-how and validated systems generated indoors are of great value in order to provide with high quality experimental designs and accurate and reliable results promoting fast decision-making
  21. 21. RESEARCH OMIC PLATFORM Genomics genomics@iislafe.es Arrays arrays_service@iislafe.es Genotiping and Sequencing Cytogenetics Cytomics cytomics@iislafe.es Analytical Unit analytical_unit@iislafe.es Metabolics/MS Proteomics It is a powerful platform for the analysis, validation and interpretation of massive data sets Merges a set of high-tech disciplines such as Genomics, Cytomics, Metabolomics and Proteomics.
  22. 22. Offers a customised global GLP service: - including analytical services, - consultancy, as well as - the development of analytical methods Request study Tailored design Resultsin compliance with regulation Quickproblem solving Fast-decisionmaking CUSTOMERNEEDS
  23. 23. Enzymatic activities Biomarkers Metabolomic profile Secondary metabolism compounds Signal transduction molecules Target molecules from biotransformation processes Expertise and professionals at your disposal for a wide variety of analytical determinations in compliance with GLP principles:
  24. 24. IDEA / PRODUCT Stock Options or Shares, Capital return Costs paid in valorization Procces
  25. 25. SHARING FUTURE VALUE
  26. 26. www.iislafe.es
  1. A particular slide catching your eye?

    Clipping is a handy way to collect important slides you want to go back to later.

×